The interference of polypharmacy and the importance of clinical pharmacy advice in the treatment of leprosy: a case-control study.

Rev Soc Bras Med Trop 2020 1;53:e20200114. Epub 2020 Jun 1.

Programa de Pós-Graduação em Ciências Médicas, Faculdade de Medicina, Universidade de Brasília, Brasília, DF, Brasil.

Introduction: Although supervised doses are essential for reducing leprosy treatment failure, the impact of specific drug interactions has rarely been assessed. This study aimed to estimate the risk of leprosy treatment suspension in patients receiving polypharmacy. METHODS We performed this case-control study in which the primary outcome was defined as the need to discontinue multibacillary leprosy treatment for at least one supervised dose, and the main risk factor was the detection of polypharmacy. Multivariate analysis by logistic regression was used for calculating odds ratio (OR).

Results: This study included 103 patients, of whom 43 needed to discontinue leprosy treatment (hemolysis = 26, hepatitis = 2, hemolysis associated with hepatitis = 6, and suspected treatment resistance = 9) and the rest did not. The severity of drug interactions had no effect on treatment discontinuation. Patients who used five or more drugs in addition to leprosy treatment had almost a 4-fold greater risk of treatment suspension (OR, 3.88; 95% confidence interval: 1.79-9.12; p < 0.001). The number of drugs used also positively influenced the occurrence of hemolysis (p < 0.001). No patient presented evidence of molecular resistance to rifampicin, dapsone, or ofloxacin treatment, as evidenced by genetic sequencing detection of rpoB, folp1, and gyrA mutations.

Conclusions: Polypharmacy has deleterious effects on the already difficult-to-adhere-to treatment of leprosy and polypharmacy induces hemolysis. Additional measures must be taken to avoid the undesirable effects of inadequate polypharmacy.

Download full-text PDF

Source
http://dx.doi.org/10.1590/0037-8682-0114-2020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269535PMC
June 2020

Publication Analysis

Top Keywords

leprosy treatment
20
treatment
11
treatment leprosy
8
treatment suspension
8
drug interactions
8
case-control study
8
leprosy
7
polypharmacy
5
treatment discontinuation
4
discontinuation patients
4
patients drugs
4
interactions treatment
4
severity drug
4
confidence interval
4
rest severity
4
drugs addition
4
addition leprosy
4
suspension 388
4
risk treatment
4
4-fold greater
4

Similar Publications